13D Filing: Perceptive Advisors and VBI Vaccines, Inc. (VBIV)

---

CUSIP No. 91822J 10 3

Item 3 Source and Amount of Funds or Other Consideration.

Item 3 is amended and supplemented as follows:

The Fund purchased the shares of Common Stock described in Item 5(c) using funds from working capital.

Item 5 Interest in Securities of the Issuer.

Item 5 is amended and restated as follows:

(a)-(b) The information required by this item with respect to each Reporting Person is set forth in Rows 7 through 11 and 13 of each cover page
to this Schedule 13D. The ownership percentages reported are based on 61,704,781 outstanding shares of Common Stock as of the completion of the offering and concurrent registered direct offering, as described in the Issuers prospectus filed on
October 27, 2017.

The Fund directly holds 9,345,725 shares of Common Stock. The Credit Fund directly holds 2,068,824 warrants each
exercisable for one share of Common Stock. The Investment Manager serves as the investment manager to the Fund and the Credit Fund and may be deemed to beneficially own the securities directly held by the Fund and the Credit Fund. Mr. Edelman
is the managing member of the Investment Manager and may be deemed to beneficially own the securities directly held by the Master Fund and the Credit Fund.

(c) On October 26, 2017, the Fund purchased 3,100,000 shares of Common Stock at a price of $3.05 per share in a privately negotiated
transaction.

(d)-(e) Not applicable